To explore the mechanisms of action of CD200R1 in HNSCC, we systematically investigated the GEO and TCGA datasets and found that CD200R1 was positively associated with an enhanced immune response. The gene discussed is CD200R1; the disease is head and neck squamous cell carcinoma.